Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene

Anaesthesia. 2012 Sep;67(9):1021-4. doi: 10.1111/j.1365-2044.2012.07226.x. Epub 2012 Jun 27.

Abstract

We present the case of a 20-year-old woman who developed rhabdomyolysis, disseminated intravascular coagulopathy and multi-organ failure induced by ecstasy. Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg.kg(-1) dantrolene. Subsequent genetic testing revealed a novel potentially pathogenic variant in the ryanodine receptor type 1 gene. However, caffeine-halothane contracture testing of the patient's mother who carried the same gene variant was negative for malignant hyperthermia.

Publication types

  • Case Reports

MeSH terms

  • Anesthetics, Inhalation
  • Antipsychotic Agents / adverse effects
  • Body Temperature
  • Caffeine
  • Central Nervous System Stimulants
  • Chromatography, High Pressure Liquid
  • Creatine Kinase / blood
  • Dantrolene / therapeutic use
  • Disseminated Intravascular Coagulation / etiology
  • Female
  • Genetic Variation
  • Hallucinogens / adverse effects*
  • Haloperidol / adverse effects
  • Halothane
  • Humans
  • Multiple Organ Failure / chemically induced
  • Multiple Organ Failure / physiopathology
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • Neuroleptic Malignant Syndrome / genetics*
  • Neuroleptic Malignant Syndrome / physiopathology*
  • Recurrence
  • Rhabdomyolysis / chemically induced*
  • Rhabdomyolysis / genetics
  • Rhabdomyolysis / physiopathology
  • Ryanodine Receptor Calcium Release Channel / genetics*
  • Spectrum Analysis
  • Young Adult

Substances

  • Anesthetics, Inhalation
  • Antipsychotic Agents
  • Central Nervous System Stimulants
  • Hallucinogens
  • Ryanodine Receptor Calcium Release Channel
  • Caffeine
  • Creatine Kinase
  • Dantrolene
  • Haloperidol
  • N-Methyl-3,4-methylenedioxyamphetamine
  • Halothane